|
2021 |
The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2021 |
Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation. |
Thomas P Davis, PhD |
|
2020 |
Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection. |
Christopher Cartmell |
|
2020 |
Daily intermittent fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation. |
John M. Streicher, PhD |
|
2020 |
Childbearing Decisions in Residency: A Multicenter Survey of Female Residents. |
Sigrid Gardner Williams |
|
2020 |
Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway. |
John M. Streicher, PhD |
|
2020 |
Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model. |
Torsten Falk, Ph.D., Robin Polt, Ph.D., Todd Vanderah, PhD |
|
2020 |
A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models. |
John M. Streicher, PhD |
|
2020 |
Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy. |
Fei Yin, Ph.D. |
|
2020 |
Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment. |
Fei Yin, Ph.D. |
|
2020 |
Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2020 |
Multifaceted roles of TAK1 signaling in cancer. |
Nam Lee, Ph.D. |
|
2020 |
Dynamic Neuroimmune Profile during Mid-life Aging in the Female Brain and Implications for Alzheimer Risk. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2020 |
Haploinsufficiency of tau decreases survival of the mouse model of Niemann-Pick disease type C1 but does not alter tau phosphorylation. |
Todd Vanderah, PhD |
|
2020 |
Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2020 |
Heat shock protein 90 inhibitors block the antinociceptive effects of opioids in mouse chemotherapy-induced neuropathy and cancer bone pain models. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD |
|
2020 |
The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. |
John M. Streicher, PhD |
|
2020 |
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Potential therapeutic treatments of cancer-induced bone pain. |
Todd Vanderah, PhD |
|
2020 |
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Glial neuroimmune signaling in opioid reward. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising. |
Todd Vanderah, PhD |
|
2020 |
Editorial: Novel Molecular Targets for the Treatment of Pain. |
John M. Streicher, PhD |
|
2020 |
Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
